The Pathogenic Role of the Adaptive Immune Response to Modified LDL in Diabetes

Frontiers in Endocrinology - Switzerland
doi 10.3389/fendo.2012.00076
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA